Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11384153 Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
July 18, 2019
Date of Patent
July 12, 2022
Patent Applicant
Regeneron Pharmaceuticals
Patent Application Number
16516028
Patent Citations
US Patent 10144782 Humanized antibodies against CD269 (BCMA)
0
US Patent 10077315 Bispecific antibodies against CD3 and BCMA
US Patent 10072088 Anti-BCMA antibodies and uses thereof
US Patent 10189906 Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
US Patent 10040860 Therapeutic antibodies and their uses
US Patent 10220090 BCMA Antigen binding proteins
US Patent 10253104 Bispecific antibodies against CD3ϵ and BCMA
Patent Citations Received
US Patent 11919965 Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies
0
Patent Inventor Names
David DiLillo
0
Jessica Kirshner
0
Frank Delfino
0
Eric Smith
0
Qian Zhang
0
Olga Sineshchekova
0
Kara Olson
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11384153
Patent Primary Examiner
Claire Kaufman
Find more entities like US Patent 11384153 Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE